Skip to content

Cardinal Health CAH Non-US — Revenue

Similar metrics at other companies

PagerDuty logo
PDNon-US — Revenue
$34.95M+3.5%
JBT Marel Corporation logo
JBTMNon-US — Revenue
$589.83M+201%
Wolverine World Wide logo
WWWNon-US — Revenue
$244.53M+13.5%
MH
MHNon-US — Revenue
$42.34M-6.7%
Oceaneering International logo
OIINon-US — Revenue
$397.66M+4.9%
Titan Machinery logo
TITNNon-US — Revenue
$60.44M-35.6%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's non-us — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's non-us — revenue?
Cardinal Health (CAH) reported non-us — revenue of $423M in Q1 2026.
How has Cardinal Health's non-us — revenue changed year-over-year?
Cardinal Health's non-us — revenue increased by 6.0% year-over-year, from $399M to $423M.
What is the long-term trend for Cardinal Health's non-us — revenue?
Over 2 years (2021 to 2025), Cardinal Health's non-us — revenue has grown at a -40.6% compound annual growth rate (CAGR), from $4.73B to $1.67B.
What does non-us — revenue mean?
This metric represents the total net sales generated by the company's operations located outside of its primary domestic market. It reflects the company's geographic diversification and its ability to capture market share in international healthcare and pharmaceutical distribution sectors. Tracking this revenue helps investors assess the impact of currency fluctuations, international regulatory environments, and global supply chain performance on overall top-line growth.